Dubai, United Arab Emirates Oct 20, 2022 (Issuewire.com) - A significant consolidation is expected in the Pharma API and core bulk drugs businesses. Pharma API is one of the most profitable sectors for growth & The change in trend has happened in the intermediate or second-rung segment engaged in the business of API, generic or bulk drug chemicals, and contract manufacturing of consumables, which are essential in the business of supplying raw materials to the frontline pharmaceutical firms. Medylife Global FZE is all set to further extend its R&D capabilities and provide cutting-edge products to the global market
Speaking on the expansion plans of Medylife Global FZE, Mr. Salim Khan, the young & energetic Managing Director of Medylife Global FZE said that “Our service goes beyond API manufacturing. We build relationships based on trust and brand prestige. At Medylife Global FZE, we work every day to continually improve our processes. We also actively research and innovate in order to bring new API’s to market and support our API pharma customers. With increasing medicine shortages that critically impact patient care, Medylife Global FZE would contribute to supporting and securing API manufacturing as well as supply capacities for Europe and beyond. In Europe, the new API industry champion is expected to help in balancing the industry’s heavy reliance on API sourced from the Asian region. Our priority currently is to cater to the growing markets in Africa & Asean Countries. Medylife Global FZE plans to increase its sales to third parties and to expand its partnerships with other pharmaceutical companies in order to take advantage of new growth opportunities and have the ability to deftly adapt to customer needs. Medylife Global FZE is uniquely positioned to benefit from its significant competitive strengths, including a broad portfolio of both volume and niche products, high standards of quality, competitive pricing, state-of-the-art industrial capabilities and technologies across Europe (including France, Italy, Germany, Hungary, and the United Kingdom) as well as leveraging an extensive commercial network covering more than 80 countries".
Medylife Global FZE is one of the fastest-growing pharmaceutical companies engaged in the business of Pharma API & Intermediaries with a significant presence in the UAE & African Markets. Medylife Global FZE within a short span of years has emerged as a trusted & reliable partner in the global market. As a pharmaceutical supplier, Medylife Global FZE has developed our product range of niche, small-molecule API’s to meet the growing demands of the pharmaceutical industry. Medylife Global FZE actively researches and innovates in order to bring new API’s to market in order to support our customers.
Medylife Global FZE has a strong leadership team ably backed by world-renowned professional business leaders as advisors to the company. Global Advisors of Medylife Global FZE is only limited to effectively guiding the management. Dr. Huzaifa Khorakiwala, the Executive Director of Wockhardt Limited, Mr. Lord Drayson, Founder Sensyne Health. Chairman Freevolt Technologies & Dr. Rajaram Samant, the Founder & CEO of the US-based Celagenex are respected names in the corporate world in the Advisory Board
Medylife Global FZE, has a Geographical advantage with its team spread across the globe. We had divided our business into 4 continents, Asia, Africa, Europe, and the US. With our team is located and placed in various locations such as UAE, London, India, Hong Kong, Singapore, South Africa, and New York, which help in sourcing the required products at much more competitive prices, best quality, and with good payment terms. Our major revenue turnover comes from Asian Countries. As global marketers of commodities, we are uniquely diversified by geography, products, and activities. Integrating our marketing and interacting skills, which sets us apart from our competitors creates a unique culture and helps to generate value for the company. Medylife Global Fze Is An International Trading And Distribution Company, Focused On The Pharma-Related Chemicals Supply Chain By Acquisition, Development, And Commercialization.
Media Contact
Medylife Global FZE *****@medylifeglobal.com +971 42221132 Office No 627 6th Floor, Building No A1 Ajman Free Zone, Ajman, UAE https://medylifeglobal.com/
